Cárdenas M, Fragoso T, Sagaró E, Longchong M, Wilson E
Hospital Pediátrico Docente Juan Manuel Marquéz, Marianao, Habana, Cuba.
Rev Gastroenterol Peru. 1996 Jan-Apr;16(1):39-42.
Liver biopsies from 27 patients with malignant diseases and virus B carriers state were studied. The age of the patients ranged from 2 to 14 years. ELISA tests for virus B hepatitis were performed in all patients. Three of them resulted HBV positive at admission, whereas 24 became positive after anti-tumoral treatment onset. One patient was also virus C positive. Morphological disorders findings comprises: symptomless acute hepatitis in 7 patients (including the B-C carrier), minimal hepatocytes damage was found in 17 patients as the result of their carriers state and where also certain drug-induced hepatotoxic effect might be present. In this group there were also 7 biopsies with minimal portal region damage. Three biopsies were reported as normal liver tissue. This results confirmed the significance of the study of serological hepatitis viral test and hepatic biopsy in high risk group patients, where it is also necessary the vaccination against HBV before treatment onset.
对27例患有恶性疾病且为乙肝病毒携带者的患者进行了肝脏活检。患者年龄在2至14岁之间。对所有患者进行了乙肝病毒肝炎的酶联免疫吸附测定(ELISA)检测。其中3例在入院时乙肝病毒检测呈阳性,而24例在开始抗肿瘤治疗后呈阳性。1例患者丙肝病毒也呈阳性。形态学紊乱的发现包括:7例患者(包括乙肝-丙肝携带者)有无症状性急性肝炎,17例患者因携带状态出现最小程度的肝细胞损伤,并且可能还存在一定的药物性肝毒性作用。该组中还有7例活检显示门静脉区损伤最小。3例活检报告为正常肝组织。这些结果证实了对高危组患者进行血清学肝炎病毒检测和肝脏活检研究的重要性,在开始治疗前对乙肝病毒进行疫苗接种也是必要的。